Article
Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer.
Clinical pharmacology and therapeutics - 1 Nov 2014
Pu X, Wang L, Chang J Y, Hildebrandt M A T, Ye Y, Lu C, Skinner H D, Niu N, Jenkins G D, Komaki R, Minna J D, Roth J A, Weinshilboum R M, Wu X
Abstract excerpt
Definitive radiotherapy improves locoregional control and survival in inoperable non-small cell lung cancer patients. However, radiation-induced toxicities (pneumonitis/esophagitis) are common dose-limiting inflammatory conditions. We therefore conducted a pathway-based analysis to identify inflammation-related single-nucleotide polymorphisms associated with radiation-induced pneumonitis or esophagitis. A total...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
